相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dihydroartemisinin as a potential drug candidate for cancer therapy: a structural-based virtual screening for multitarget profiling
Ibrahim Malami et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Biochemical aspects and therapeutic mechanisms of cannabidiol in epilepsy
Ana Paula de A. Boleti et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2022)
Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis
Nicholas Dopkins et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2022)
Use of cannabidiol in the treatment of epilepsy
Maria Mazurkiewicz-Beldzinska et al.
NEUROLOGIA I NEUROCHIRURGIA POLSKA (2022)
Prophylactic Administration of Cannabidiol Reduces Microglial Inflammatory Response to Kainate-Induced Seizures and Neurogenesis
Tanya R. Victor et al.
NEUROSCIENCE (2022)
NEUROPATHIC PAIN: FROM MECHANISMS TO TREATMENT
Nanna Brix Finnerup et al.
PHYSIOLOGICAL REVIEWS (2021)
Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview
Carlos Villarroel-Vicente et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng et al.
NATURE REVIEWS NEUROLOGY (2021)
Effects of Cannabidiol and Beta-Caryophyllene Alone or in Combination in a Mouse Model of Permanent Ischemia
Cody G. Yokubaitis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research
Valentina Franco et al.
NEUROPHARMACOLOGY (2021)
Neuroprotective versus Neuroinflammatory Roles of Complement: From Development to Disease
Marlene Kanmogne et al.
TRENDS IN NEUROSCIENCES (2021)
Impact of Stress on Epilepsy: Focus on Neuroinflammation-A Mini Review
Claudia Espinosa-Garcia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cannabinoid Quinones-A Review and Novel Observations
Natalya M. Kogan et al.
MOLECULES (2021)
Studies of involvement of G-protein coupled receptor-3 in cannabidiol effects on inflammatory responses of mouse primary astrocytes and microglia
Jun Wu et al.
PLOS ONE (2021)
Mechanisms of Drug Resistance in the Pathogenesis of Epilepsy: Role of Neuroinflammation. A Literature Review
Elena D. Bazhanova et al.
BRAIN SCIENCES (2021)
Cannabidiol-dihydroartemisinin conjugates for ameliorating neuroinflammation with reduced cytotoxicity
Fanfan Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Neuroinflammation: A Signature or a Cause of Epilepsy?
Enrico Pracucci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson's Disease
Sonia Burgaz et al.
MOLECULES (2021)
Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies A Nonrandomized Controlled Trial
Ingrid E. Scheffer et al.
JAMA NETWORK OPEN (2021)
Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-κB-dependent signaling and glucose consumption
Mauricio dos-Santos-Pereira et al.
GLIA (2020)
The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities
Dixon H. Xu et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2020)
Abnormal Cannabidiol Affects Production of Pro-Inflammatory Mediators and Astrocyte Wound Closure in Primary Astrocytic-Microglial Cocultures
Julian Cardinal von Widdern et al.
MOLECULES (2020)
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Sinemyiz Atalay et al.
ANTIOXIDANTS (2020)
Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes
Dan Jin et al.
SCIENTIFIC REPORTS (2020)
Inflammation in Neurological Disorders: The Thin Boundary Between Brain and Periphery
Carlo Cervellati et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
The Role of Neuroinflammation in Cellular Damage in Neurodegenerative Diseases
Sangu Muthuraju et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Cannabidiol anticonvulsant effect is mediated by the PI3Kγ pathway
Isabel Vieira de Assis Lima et al.
NEUROPHARMACOLOGY (2020)
Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
Umberto Raucci et al.
FRONTIERS IN PHARMACOLOGY (2020)
Access to cannabidiol without a prescription: A cross-country comparison and analysis
Iain S. McGregor et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2020)
Safety and Tolerability of Cannabidiol in Parkinson Disease: An Open Label, Dose-Escalation Study
Maureen A. Leehey et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Hypoxia-inducible factor-2α is crucial for proper brain development
Kira Kleszka et al.
SCIENTIFIC REPORTS (2020)
Is cannabidiol a drug acting on unconventional targets to control drug-resistant epilepsy?
Luisa Rocha et al.
EPILEPSIA OPEN (2020)
Sativex® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
Jolana Markova et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2019)
Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage
Lorena Barata et al.
NEUROPHARMACOLOGY (2019)
Cannabinoid therapy in epilepsy
Santoshi Billakota et al.
CURRENT OPINION IN NEUROLOGY (2019)
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Serena Silvestro et al.
MOLECULES (2019)
Microglia-mediated neuroinflammation in neurodegenerative diseases
Charannya Sozheesvari Subhramanyam et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome
Zinah Zamil Al-Ghezi et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Cannabidiol Adverse Effects and Toxicity
Marilyn A. Huestis et al.
CURRENT NEUROPHARMACOLOGY (2019)
Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
Annamaria Vezzani et al.
NATURE REVIEWS NEUROLOGY (2019)
Modifiable Risk Factors for Alzheimer's Disease
George A. Edwards et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
Combination of Cannabinoids, Δ9-Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
Zinah Zamil Al-Ghezi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US
Tristan T. Sands et al.
CNS DRUGS (2019)
Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Ila M. Linares et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2019)
Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy
Kerstin A. Klotz et al.
FRONTIERS IN NEUROLOGY (2019)
Medical cannabis: aligning use to evidence-based medicine approach
Lihi Bar-Lev Schleider et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice
Hongbo Li et al.
CELLULAR IMMUNOLOGY (2018)
Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results
Jerzy P. Szaflarski et al.
EPILEPSIA (2018)
Inflammation in CNS neurodegenerative diseases
Jodie Stephenson et al.
IMMUNOLOGY (2018)
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy
Carmen Navarrete et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
Jerzy P. Szaflarski et al.
EPILEPSY & BEHAVIOR (2018)
Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
David M. Elliott et al.
FRONTIERS IN IMMUNOLOGY (2018)
Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
Simona Lattanzi et al.
DRUGS (2018)
Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
Kerri A. Schoedel et al.
EPILEPSY & BEHAVIOR (2018)
Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases
Jacqueline S. Gofshteyn et al.
JOURNAL OF CHILD NEUROLOGY (2017)
Insights Into the Neuroinflammatory Responses After Neonatal Hypoxia-Ischemia
Malgorzata Ziemka-Nalecz et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2017)
Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke
Maria Ceprian et al.
NEUROPHARMACOLOGY (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
Alline C. Campos et al.
FRONTIERS IN PHARMACOLOGY (2017)
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
Paula Morales et al.
FRONTIERS IN PHARMACOLOGY (2017)
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
Antonio W. Zuardi et al.
Frontiers in Pharmacology (2017)
Protective effects of cannabidiol on cuprizone-induced demyelination in C57BL/6 mice
Maryam Sajjadian et al.
JOURNAL OF CONTEMPORARY MEDICAL SCIENCES (2017)
Microglial activation and progressive brain changes in schizophrenia
L. E. Laskaris et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
An update on PPAR activation by cannabinoids
Saoirse Elizabeth O'Sullivan
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Polypharmacological Properties and Therapeutic Potential of beta-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Charu Sharma et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Cannabidiol, neuroprotection and neuropsychiatric disorders
Alline C. Campos et al.
PHARMACOLOGICAL RESEARCH (2016)
Cannabis sativa: The Plant of the Thousand and One Molecules
Christelle M. Andre et al.
FRONTIERS IN PLANT SCIENCE (2016)
Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders
Heeok Hong et al.
INTERNATIONAL NEUROUROLOGY JOURNAL (2016)
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
Sumner Burstein
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol
Felipe V. Gomes et al.
SCHIZOPHRENIA RESEARCH (2015)
Microglia Development and Function
Debasis Nayak et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Oligodendrocyte-Encoded HIF Function Couples Postnatal Myelination and White Matter Angiogenesis
Tracy J. Yuen et al.
CELL (2014)
Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial
Marcos Hortes N. Chagas et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Manuel A. Friese et al.
NATURE REVIEWS NEUROLOGY (2014)
Protective Effects of Cannabidiol Against Hippocampal Cell Death and Cognitive Impairment Induced by Bilateral Common Carotid Artery Occlusion in Mice
Angelica Pupin Schiavon et al.
NEUROTOXICITY RESEARCH (2014)
Hypoxia-Induced Secretion of TGF-β1 in Mesenchymal Stem Cell Promotes Breast Cancer Cell Progression
Shun-Pei Hung et al.
CELL TRANSPLANTATION (2013)
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
M. Mecha et al.
NEUROBIOLOGY OF DISEASE (2013)
Cannabis, a complex plant: different compounds and different effects on individuals
Zerrin Atakan
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2012)
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
Ewa Kozela et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment
L. De Santi et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
Lourdes Ruiz-Valdepenas et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Jose Alexandre S. Crippa et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
Ana Maria Martin-Moreno et al.
MOLECULAR PHARMACOLOGY (2011)
Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells
Ewa Kozela et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
C. Collin et al.
NEUROLOGICAL RESEARCH (2010)
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets
Francisco J. Alvarez et al.
PEDIATRIC RESEARCH (2008)
Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons
Shuzhen Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
New cannabidiol derivatives: Synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity
S Ben-Shabat et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Neuroinflammation: a potential therapeutic target
JM Craft et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
DT Wade et al.
MULTIPLE SCLEROSIS (2004)
Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells
Q Shen et al.
SCIENCE (2004)
分享论文
